Literature DB >> 16718463

Signalling mechanisms linking hepatic glucose and lipid metabolism.

M O Weickert1, A F H Pfeiffer.   

Abstract

Fatty liver and hepatic triglyceride accumulation are strongly associated with obesity, insulin resistance and type 2 diabetes, and are subject to nutritional influences. Hepatic regulation of glucose and lipid homeostasis is influenced by a complex system of hormones, hormonally regulated signalling pathways and transcription factors. Recently, considerable progress has been made in elucidating molecular pathways and potential factors that are affected in insulin-resistant states. In this review we discuss some of the key factors that are involved in both the regulation of glucose and lipid metabolism in the liver. Understanding the molecular network that links hepatic lipid accumulation and impaired glucose metabolism may provide targets for dietary or pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718463     DOI: 10.1007/s00125-006-0295-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  117 in total

Review 1.  AMP-activated protein kinase: balancing the scales.

Authors:  David Carling
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

2.  Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.

Authors:  H J Harris; Y Kotelevtsev; J J Mullins; J R Seckl; M C Holmes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

3.  Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level.

Authors:  A H Hasty; H Shimano; N Yahagi; M Amemiya-Kudo; S Perrey; T Yoshikawa; J Osuga; H Okazaki; Y Tamura; Y Iizuka; F Shionoiri; K Ohashi; K Harada; T Gotoda; R Nagai; S Ishibashi; N Yamada
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

4.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

Review 5.  Role of stearoyl-coenzyme A desaturase in lipid metabolism.

Authors:  Makoto Miyazaki; James M Ntambi
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-02       Impact factor: 4.006

Review 6.  Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.

Authors:  Neil B Ruderman; Asish K Saha; Edward W Kraegen
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

7.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.

Authors:  Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

8.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

9.  Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

Authors:  Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  36 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

2.  Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.

Authors:  Ajit Vikram; Gopabandhu Jena; Poduri Ramarao
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Comment on: Weickert MO, Pfeiffer AFH (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741.

Authors:  R N A Black; P M Bell
Journal:  Diabetologia       Date:  2006-12-06       Impact factor: 10.122

4.  Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.

Authors:  Deqiang Zhang; Xin Tong; Blake Arthurs; Anirvan Guha; Liangyou Rui; Avani Kamath; Ken Inoki; Lei Yin
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 5.  Hepatitis C virus infection and insulin resistance.

Authors:  Sandip K Bose; Ranjit Ray
Journal:  World J Diabetes       Date:  2014-02-15

Review 6.  JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.

Authors:  Giovanni Tarantino; Armando Caputi
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

7.  Overexpression of Nudt7 decreases bile acid levels and peroxisomal fatty acid oxidation in the liver.

Authors:  Stephanie A Shumar; Evan W Kerr; Paolo Fagone; Aniello M Infante; Roberta Leonardi
Journal:  J Lipid Res       Date:  2019-03-07       Impact factor: 5.922

Review 8.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

9.  Methionine deficiency and hepatic injury in a dietary steatohepatitis model.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

10.  Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.

Authors:  Lauren M Aleksunes; Scott A Reisman; Ronnie L Yeager; Michael J Goedken; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2010-01-19       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.